Table 1.
Study | Location | No. of Included Patients | Mean Age at Time of Surgery, y | Mean Follow-up, mo (range) | Mean MINORS Score | Level of Evidence |
---|---|---|---|---|---|---|
Boesmueller et al, 20172 | Austria | 11 | 31.8 | 41.9 (36.1-48.4) | 14/16 | 4 |
Boileau et al, 20093 | France | 10 | 37 | 35 (24-69) | 20/24 | 2 |
Brockmeier et al, 20094 | USA | 47 | 36 | 32.3 (25.1-48.7) | 12/16 | 4 |
Chalmers et al, 20168 | USA | 45 | 35 | 49.2 (12.0-58.8) | 9.5/16 | 3 |
Cohen et al, 20069 | USA | 29 | 34 | 44 (25-97) | 10/16 | 4 |
Denard et al, 201410 | USA | 20 | 45.2 | 63.2b | 10/16 | 4 |
Fedoriw et al, 201411 | USA | 40 | 23.7 | — | 10.5/16 | 4 |
Friel et al, 201012 | USA | 48 | 33.1 | 40.8 (24-68.4) | 10.5/16 | 4 |
Gilliam et al, 201813 | USA | 133 | 19.5 | 78 (27-146) | 9.5/16 | 4 |
Ide et al, 200516 | Japan | 40 | 26 | 41 (24-58) | 10.5/16 | 4 |
Kim et al, 201217 | South Korea | 14 | 26 | 31.4 (25-46) | 20/24 | 2 |
Kim et al, 200218 | South Korea | 34 | 39.1 | 33b | 10/16 | 4 |
Maier et al, 201320 | Germany | 24 | 36.5 | 46.2b | 19.5/24 | 4 |
Neri et al, 201123 | USA | 50 | 35 | 41.5 (18-45) | 9/16 | 2 |
Neuman et al, 201124 | USA | 30 | 24 | 42 (18-96) | 11/16 | 4 |
Park et al, 201325 | South Korea | 24 | 22.7 | 45.8 (24-68) | 10/16 | 4 |
Provencher et al, 201327 | USA | 179 | 31.6 | 40.4 (26-62) | 10.5/16 | 3 |
Rhee et al, 200528 | South Korea | 41 | 24 | 33 (25-67) | 11/16 | 4 |
Samani et al, 200129 | USA | 25 | 36 | 35 (24-51) | 10.5/16 | 4 |
Smith et al, 201633 | USA | 24 | 27.8 | — | 9.5/16 | 4 |
Waterman et al, 201537 | USA | 60 | 35 | 50b | 17.5/24 | 3 |
Yung et al, 200838 | China | 16 | 24.2 | 27.6 (24-31) | 11/16 | 2 |
MINORS, Methodological Index for Non-Randomized Studies; SLAP, superior labral anterior-posterior.
Dashes refer to data not reported.
Unavailable range.